scholarly article | Q13442814 |
P2093 | author name string | Tadashi Matsuda | |
Tetsuya Yamamoto | |||
Yuichi Sekine | |||
Noriko Sato | |||
Naohito Aoki | |||
Atsuko Kubota | |||
Keiichi Kashima | |||
P2860 | cites work | SOCS-1 can suppress CD3zeta- and Syk-mediated NF-AT activation in a non-lymphoid cell line | Q40883091 |
Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling | Q42823926 | ||
Cellular stress regulates the nucleocytoplasmic distribution of the protein-tyrosine phosphatase TCPTP. | Q42826816 | ||
Signaling mechanisms through gp130: a model of the cytokine system | Q47992455 | ||
Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells | Q64389144 | ||
TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B | Q24291860 | ||
A family of cytokine-inducible inhibitors of signalling | Q24313168 | ||
A new protein containing an SH2 domain that inhibits JAK kinases | Q24313242 | ||
Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin | Q24313509 | ||
Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase | Q24522441 | ||
Cloning and characterization of a mouse cDNA encoding a cytoplasmic protein-tyrosine-phosphatase | Q24563410 | ||
cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family | Q24611364 | ||
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins | Q27860890 | ||
A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus | Q28214398 | ||
Specific inhibition of Stat3 signal transduction by PIAS3 | Q28255665 | ||
Cytokine signal transduction | Q28258951 | ||
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 | Q28279735 | ||
Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells | Q28571171 | ||
Structure and function of a new STAT-induced STAT inhibitor | Q28584775 | ||
Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice | Q28594549 | ||
Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway | Q28609398 | ||
Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression | Q28638072 | ||
Plat-E: an efficient and stable system for transient packaging of retroviruses | Q29614830 | ||
Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene | Q29618933 | ||
Expression of a human T-cell protein-tyrosine-phosphatase in baby hamster kidney cells | Q33804441 | ||
A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b | Q33918209 | ||
Combinatorial control of the specificity of protein tyrosine phosphatases | Q34180660 | ||
Protein tyrosine phosphatase 1B interacts with the activated insulin receptor | Q34399346 | ||
Protein tyrosine phosphatases in signal transduction. | Q34419522 | ||
Interleukin-6 and its receptor: a paradigm for cytokines | Q35425050 | ||
Nuclear localization and cell cycle regulation of a murine protein tyrosine phosphatase | Q36652002 | ||
A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells | Q38355379 | ||
Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells. | Q39446572 | ||
Cytokine receptor signalling | Q40416594 | ||
Cross-talk between signal transducer and activator of transcription 3 and estrogen receptor signaling | Q40838022 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | signal transducer and activator of transcription 3 | Q4210010 |
interleukins | Q194908 | ||
interleukin-6-mediated signaling pathway | Q14865234 | ||
P304 | page(s) | 811-7 | |
P577 | publication date | 2002-10-04 | |
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation | |
P478 | volume | 297 |
Q34801318 | Activation of T-cell protein-tyrosine phosphatase suppresses keratinocyte survival and proliferation following UVB irradiation |
Q34989162 | Activation of protein tyrosine phosphatase non-receptor type 2 by spermidine exerts anti-inflammatory effects in human THP-1 monocytes and in a mouse model of acute colitis |
Q35140327 | Adenovirus sequesters phosphorylated STAT1 at viral replication centers and inhibits STAT dephosphorylation |
Q37179677 | Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1. |
Q39194921 | CREB, NF-κB, and NADPH oxidase coordinately upregulate indoxyl sulfate-induced angiotensinogen expression in proximal tubular cells. |
Q37505664 | Cell and molecular biology of the novel protein tyrosine-phosphatase-interacting protein 51. |
Q40580990 | Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells |
Q36512624 | Central regulation of metabolism by protein tyrosine phosphatases |
Q91591537 | Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia |
Q37075035 | Critical analysis of the potential for targeting STAT3 in human malignancy |
Q92406835 | DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells |
Q44384572 | Different patterns of regulation of Tyr-phosphorylated STAT1 and STAT3 in human hepatoma Hep3B cells by the phosphatase inhibitor orthovanadate |
Q35686688 | Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance |
Q35091267 | Gambogic acid inhibits STAT3 phosphorylation through activation of protein tyrosine phosphatase SHP-1: potential role in proliferation and apoptosis |
Q33678110 | Genetic variants of PTPN2 are associated with lung cancer risk: a re-analysis of eight GWASs in the TRICL-ILCCO consortium |
Q35921093 | Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis |
Q38779744 | Ginkgetin Blocks Constitutive STAT3 Activation and Induces Apoptosis through Induction of SHP-1 and PTEN Tyrosine Phosphatases. |
Q28482163 | Icariside II induces apoptosis in U937 acute myeloid leukemia cells: role of inactivation of STAT3-related signaling |
Q24300141 | Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T |
Q33527394 | Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse |
Q30976460 | Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase |
Q93020284 | Intragenic regulation of SOCS3 isoforms |
Q34174084 | Involvement of heat-shock protein 90 in the interleukin-6-mediated signaling pathway through STAT3. |
Q36176015 | JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia |
Q53441039 | Loss of T-cell protein tyrosine phosphatase in the intestinal epithelium promotes local inflammation by increasing colonic stem cell proliferation. |
Q34212116 | Loss of protein tyrosine phosphatase N2 potentiates epidermal growth factor suppression of intestinal epithelial chloride secretion |
Q35138365 | Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels |
Q41218016 | Microbial sensing by the intestinal epithelium in the pathogenesis of inflammatory bowel disease |
Q43850656 | Model Based Targeting of IL-6-Induced Inflammatory Responses in Cultured Primary Hepatocytes to Improve Application of the JAK Inhibitor Ruxolitinib. |
Q39328853 | Model-driven experimental analysis of the function of SHP-2 in IL-6-induced Jak/STAT signaling. |
Q28178841 | Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor |
Q58884834 | Molecular targets for cell cycle inhibition and cancer therapy |
Q38587970 | Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches |
Q40066648 | NRAMP-1 expression modulates protein-tyrosine phosphatase activity in macrophages: impact on host cell signaling and functions |
Q33430520 | Narrative-based computational modelling of the Gp130/JAK/STAT signalling pathway |
Q92748155 | Neonatal nutritional programming induces gliosis and alters the expression of T-cell protein tyrosine phosphatase and connexins in male rats |
Q28479009 | Over-expression of leptin receptors in hypothalamic POMC neurons increases susceptibility to diet-induced obesity |
Q40901310 | PASD1 promotes STAT3 activity and tumor growth by inhibiting TC45-mediated dephosphorylation of STAT3 in the nucleus |
Q39430711 | PDLIM2 inhibits T helper 17 cell development and granulomatous inflammation through degradation of STAT3. |
Q36800460 | PRISM offers a comprehensive genomic approach to transcription factor function prediction |
Q37992232 | PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis |
Q54537231 | Phospho-Ser727 of STAT3 regulates STAT3 activity by enhancing dephosphorylation of phospho-Tyr705 largely through TC45. |
Q24530173 | Principles of interleukin (IL)-6-type cytokine signalling and its regulation |
Q33858319 | Proinflammatory stem cell signaling in cardiac ischemia |
Q33793839 | Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2 |
Q36128506 | Protein Tyrosine Phosphatase N2 Is a Positive Regulator of Lipopolysaccharide Signaling in Raw264.7 Cell through Derepression of Src Tyrosine Kinase |
Q99711518 | Protein Tyrosine Phosphatase Non-Receptor Type 2 Function in Dendritic Cells Is Crucial to Maintain Tissue Tolerance |
Q42905042 | Protein Tyrosine Phosphatase non-Receptor Type 2 regulates IFN-γ-induced cytokine signaling in THP-1 monocytes |
Q39233347 | Protein Tyrosine Phosphatases in Systemic Sclerosis: Potential Pathogenic Players and Therapeutic Targets. |
Q54354623 | Protein tyrosine phosphatase 1B is a regulator of the interleukin-10-induced transcriptional program in macrophages. |
Q36713273 | Protein tyrosine phosphatase function: the substrate perspective |
Q42479250 | Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblasts. |
Q37088189 | Protein tyrosine phosphatases and type 1 diabetes: genetic and functional implications of PTPN2 and PTPN22 |
Q26861574 | Protein tyrosine phosphatases as wardens of STAT signaling |
Q33565458 | Protein tyrosine phosphatases, TC-PTP, SHP1, and SHP2, cooperate in rapid dephosphorylation of Stat3 in keratinocytes following UVB irradiation |
Q37094065 | Protein tyrosine phosphatases: regulatory mechanisms |
Q37998155 | Regulating naïve and memory CD8 T cell homeostasis--a role for protein tyrosine phosphatases |
Q39336319 | Regulation of epithelial barrier function by the inflammatory bowel disease candidate gene, PTPN2. |
Q35934532 | Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma |
Q38962315 | Role of STAT3 in Genesis and Progression of Human Malignant Gliomas. |
Q39968995 | STAP-2 negatively regulates both canonical and noncanonical NF-kappaB activation induced by Epstein-Barr virus-derived latent membrane protein 1. |
Q38671957 | STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications |
Q37423674 | SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer |
Q36231715 | Selective STAT3-α or -β expression reveals spliceform-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes |
Q35878024 | Selenate enhances STAT3 transcriptional activity in endothelial cells: differential actions of selenate and selenite on LIF cytokine signaling and cell viability |
Q37351905 | Shared Genetic Etiology of Autoimmune Diseases in Patients from a Biorepository Linked to De-identified Electronic Health Records |
Q26775416 | Signal transducer and activator of transcription 3 regulation by novel binding partners |
Q35120899 | Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. |
Q37289295 | Spermidine stimulates T cell protein-tyrosine phosphatase-mediated protection of intestinal epithelial barrier function. |
Q34270913 | Strain-dependent differences in bone development, myeloid hyperplasia, morbidity and mortality in ptpn2-deficient mice. |
Q46115480 | T cell protein tyrosine phosphatase prevents STAT1 induction of claudin-2 expression in intestinal epithelial cells. |
Q28592080 | T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis |
Q24338883 | T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6 |
Q37460331 | TC-PTP is required for the maintenance of MYC-driven B-cell lymphomas |
Q47632031 | TGF-β and IL-6 family signalling crosstalk: an integrated model |
Q64092255 | TRIM52 promotes colorectal cancer cell proliferation through the STAT3 signaling |
Q47828321 | TRIM59 promotes gliomagenesis by inhibiting TC45 dephosphorylation of STAT3. |
Q58377593 | The Role of TCPTP in Cancer |
Q38738094 | The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling. |
Q46907819 | The catalytic activity of the eukaryotic initiation factor-2alpha kinase PKR is required to negatively regulate Stat1 and Stat3 via activation of the T-cell protein-tyrosine phosphatase |
Q39439209 | The kinase c-Src and the phosphatase TC45 coordinately regulate c-Fos tyrosine phosphorylation and c-Fos phospholipid synthesis activation capacity |
Q91864877 | The molecular details of cytokine signaling via the JAK/STAT pathway |
Q36759890 | The nucleus- and endoplasmic reticulum-targeted forms of protein tyrosine phosphatase 61F regulate Drosophila growth, life span, and fecundity |
Q40617733 | The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling |
Q34342251 | Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway |
Q92361919 | Tyrosine-protein phosphatase non-receptor type 2 inhibits alveolar bone resorption in diabetic periodontitis via dephosphorylating CSF1 receptor |
Q47132106 | UVB-induced nuclear translocation of TC-PTP by AKT/14-3-3σ axis inhibits keratinocyte survival and proliferation |
Q33275937 | Use of suppression subtractive hybridization to identify genes regulated by ciliary neurotrophic factor in postnatal retinal explants. |
Q38149939 | gp130: a promising drug target for cancer therapy |
Q37367013 | β-Arrestin 1's Interaction with TC45 Attenuates Stat signaling by dephosphorylating Stat to inhibit antimicrobial peptide expression |
Q34236653 | γ-Tocotrienol but not γ-tocopherol blocks STAT3 cell signaling pathway through induction of protein-tyrosine phosphatase SHP-1 and sensitizes tumor cells to chemotherapeutic agents |
Q34919598 | γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent |
Search more.